Enhanced growth of seed viruses for H5N1 influenza vaccines.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Virology

• Publication date

  2007-09-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.VIROL.2007.07.002PMID 17651774PMCID PMC2827194
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate.

  2006cited by this paper
• Flu-vaccine makers toil to boost supply

  2006influential reference
• Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

  2006cited by this paper
• Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system.

  2005cited by this paper
• Influenza: lessons from past pandemics, warnings from current incidents

  2005cited by this paper
• Improvement of Influenza A/Fujian/411/02 (H3N2) Virus Growth in Embryonated Chicken Eggs by Balancing the Hemagglutinin and Neuraminidase Activities, Using Reverse Genetics

  2005cited by this paper
• From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza

  2004cited by this paper
• Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines

  2004cited by this paper
• Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus

  2004cited by this paper
• Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.

  2003cited by this paper
• Development of Vero cell-derived inactivated Japanese encephalitis vaccine.

  2002cited by this paper
• Molecular Basis for High Virulence of Hong Kong H5N1 Influenza A Viruses

  2001cited by this paper
• Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase.

  2000cited by this paper
• Generation of influenza A viruses entirely from cloned cDNAs.

  1999cited by this paper
• Antiviral Activity of Antiserum Specific for an Influenza Virus Neuraminidase

  1968cited by this paper

• An avian-origin internal backbone effectively increases the H5 subtype avian influenza vaccine candidate yield in both chicken embryonated eggs and MDCK cells

  2024cites this paper
• Evaluation of inactivated avian influenza virus and Newcastle disease virus bivalent vaccination program against newly circulated H5N8 and NDV strains

  2023cites this paper
• Identification of the properties of H5 influenza vaccine viruses with high hemagglutinin yields

  2023cites this paper
• Receptor-Binding Specificity of Influenza Viruses.

  2022cites this paper
• Phylogenetic Analysis and Assessment of the Pathogenic Potential of Avian In�uenza Virus H9N2 in Wild Waterfowl, Wild Birds, and Lagoon Water in Tunisia

  2021cites this paper
• Construction and identification of influenza plasmid pool imparting high yields to candidate vaccine viruses in Vero cell at low temperature

  2020cites this paper
• Development of an effective contemporary trivalent avian influenza vaccine against circulating H5N1, H5N8, and H9N2 in Egypt.

  2019influential citation
• [Strategies for producing high-yield viral vaccine antigens].

  2017cites this paper
• Evaluation of seasonal influenza vaccines for H1N1pdm09 and type B viruses based on a replication-incompetent PB2-KO virus.

  2017cites this paper
• Construction and comparison of different source neuraminidase candidate vaccine strains for human infection with Eurasian avian-like influenza H1N1 virus.

  2017cites this paper
• Construction of Indonesian-Strain Avian Flu Virus Seed Vaccine Using Low Pathogenic Hemagglutinin Gene and Neuraminidase Pr8 Gene through Reverse Genetics

  2017cites this paper
• Generation of a reassortant avian influenza virus H5N2 vaccine strain capable of protecting chickens against infection with Egyptian H5N1 and H9N2 viruses.

  2016cites this paper
• Toll-like receptor 9 ligand D-type oligodeoxynucleotide D35 as a broad inhibitor for influenza A virus replication that is associated with suppression of neuraminidase activity

  2016cites this paper
• Error-prone pcr-based mutagenesis strategy for rapidly generating high-yield influenza vaccine candidates.

  2015cites this paper
• Identification of Influenza A/PR/8/34 Donor Viruses Imparting High Hemagglutinin Yields to Candidate Vaccine Viruses in Eggs

  2015cites this paper
• A Vero-cell-adapted vaccine donor strain of influenza A virus generated by serial passages.

  2015cites this paper
• New Methodological Approaches in The Development of Russian Live Attenuated Vaccine for Pandemic Influenza

  2015cites this paper
• Development of high-yield influenza A virus vaccine viruses

  2015cites this paper
• Dextran sulfate-resistant A/Puerto Rico/8/34 influenza virus is associated with the emergence of specific mutations in the neuraminidase glycoprotein.

  2014cites this paper
• A recombinant influenza virus vaccine expressing the F protein of respiratory syncytial virus

  2014cites this paper
• Reverse Genetics Approaches for Rational Design of Inactivated and Live Attenuated Influenza Vaccines

  2014cites this paper
• A promoter mutation in the haemagglutinin segment of influenza A virus generates an effective candidate live attenuated vaccine

  2014cites this paper
• Molecular Signature of High Yield (Growth) Influenza A Virus Reassortants Prepared as Candidate Vaccine Seeds

  2013cites this paper
• Establishment of Vero cell RNA polymerase I-driven reverse genetics for Influenza A virus and its application for pandemic (H1N1) 2009 influenza virus vaccine production.

  2013cites this paper
• Permissible Variation in the 3′ Non-Coding Region of the Haemagglutinin Genome Segment of the H5N1 Candidate Influenza Vaccine Cirus NIBRG-14

  2012cites this paper
• Improvement of influenza vaccine strain A/Vietnam/1194/2004 (H5N1) growth with the neuraminidase packaging sequence from A/Puerto Rico/8/34

  2012cites this paper
• Influenza virus neuraminidase contributes to the dextran sulfate-dependent suppressive replication of some influenza A virus strains.

  2012cites this paper
• High-yield production of a stable Vero cell-based vaccine candidate against the highly pathogenic avian influenza virus H5N1.

  2012cites this paper
• A replication-incompetent virus possessing an uncleavable hemagglutinin as an influenza vaccine.

  2012cites this paper
• Construction and Immunogenicity Study of a Veterinary Recombinant Influenza A (H1N1) Inactivated Vaccine

  2012cites this paper
• Replication-incompetent influenza A viruses that stably express a foreign gene.

  2011cites this paper
• Adaptation of High-Growth Influenza H5N1 Vaccine Virus in Vero Cells: Implications for Pandemic Preparedness

  2011cites this paper
• Enhanced Growth of Influenza Vaccine Seed Viruses in Vero Cells Mediated by Broadening the Optimal pH Range for Virus Membrane Fusion

  2011cites this paper
• Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17-18 February 2011.

  2011cites this paper
• Improvement of the H5N1 influenza virus vaccine strain to decrease the pathogenicity in chicken embryos

  2011cites this paper
• Improvement of H5N1 influenza vaccine viruses: influence of internal gene segments of avian and human origin on production and hemagglutinin content.

  2011cites this paper
• Increase in viral yield in eggs and MDCK cells of reassortant H5N1 vaccine candidate viruses caused by insertion of 38 amino acids into the NA stalk.

  2011cites this paper
• The development of vaccine viruses against pandemic A(H1N1) influenza.

  2011cites this paper
• New technologies for the control of influenza

  2010cites this paper
• Improved haemagglutinin antigen content in H5N1 candidate vaccine viruses with chimeric haemagglutinin molecules.

  2010cites this paper
• Influence des escargots d'eau (Pomacea canaliculata) sur la persistance du virus H5N1 dans l'environnement

  2010cites this paper
• Developing Vaccines to Combat Pandemic Influenza

  2010cites this paper
• Rapid generation of a well-matched vaccine seed from a modern influenza A virus primary isolate without recourse to eggs.

  2010cites this paper
• Repository of Eurasian influenza A virus hemagglutinin and neuraminidase reverse genetics vectors and recombinant viruses.

  2010cites this paper
• Optimizing Viral Protein Yield of Influenza Virus Strain A/Vietnam/1203/2004 by Modification of the Neuraminidase Gene

  2009cites this paper
• Designing vaccines for pandemic influenza.

  2009influential citation
• Construction and application of the recombinant influenza viruses

  2009cites this paper
• MDCK-SIAT1 Cells Show Improved Isolation Rates for Recent Human Influenza Viruses Compared to Conventional MDCK Cells

  2008cites this paper
• Growth Determinants for H5N1 Influenza Vaccine Seed Viruses in MDCK Cells

  2008influential citation
• Cross-clade protective immunity of H5N1 influenza vaccines in a mouse model.

  2008cites this paper
• Quantitation of haemagglutinin in H5N1 influenza viruses reveals low haemagglutinin content of vaccine virus NIBRG-14 (H5N1).

  2008cites this paper
• Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines.

  2008cites this paper
• Establishment of Canine RNA Polymerase I-Driven Reverse Genetics for Influenza A Virus: Its Application for H5N1 Vaccine Production

  2007cites this paper